Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0YE4B
|
|||
Former ID |
DNC007797
|
|||
Drug Name |
1-phenyl-3-(2-(pyridin-4-yl)thiazol-4-yl)urea
|
|||
Synonyms |
acyclic urea, 1; CHEMBL392228; BDBM20816
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H12N4OS
|
|||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)NC2=CSC(=N2)C3=CC=NC=C3
|
|||
InChI |
1S/C15H12N4OS/c20-15(17-12-4-2-1-3-5-12)19-13-10-21-14(18-13)11-6-8-16-9-7-11/h1-10H,(H2,17,19,20)
|
|||
InChIKey |
AXDWPTZOIRLDDO-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cyclin-dependent kinase 5 (CDK5) | Target Info | Inhibitor | [1] |
KEGG Pathway | Axon guidance | |||
Alzheimer's disease | ||||
Cocaine addiction | ||||
NetPath Pathway | EGFR1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Panther Pathway | Axon guidance mediated by semaphorins | |||
Pathway Interaction Database | Reelin signaling pathway | |||
Glucocorticoid receptor regulatory network | ||||
Lissencephaly gene (LIS1) in neuronal migration and development | ||||
EPHA forward signaling | ||||
Trk receptor signaling mediated by the MAPK pathway | ||||
Reactome | DARPP-32 events | |||
CRMPs in Sema3A signaling | ||||
Factors involved in megakaryocyte development and platelet production | ||||
WikiPathways | DNA Damage Response | |||
BDNF signaling pathway | ||||
Alzheimers Disease | ||||
Opioid Signalling | ||||
Semaphorin interactions | ||||
Factors involved in megakaryocyte development and platelet production | ||||
Nicotine Activity on Dopaminergic Neurons | ||||
miRNA Regulation of DNA Damage Response |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorg Med Chem. 2007 Oct 15;15(20):6574-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.